<?xml version="1.0" encoding="UTF-8"?>
<p id="Par110">Among bacteria, 
 <italic>Bacillus anthracis</italic> is one of the most concerning species. 
 <italic>B. anthracis</italic> is a fatal pathogen that causes severe anthrax disease in humans and has been used as a biological weapon. Although antibiotics are available for anthrax treatment and as post-exposure prophylaxis, anti-anthrax protective antibodies from single human B cells will still be a crucial addition to the treatment toolkit [
 <xref ref-type="bibr" rid="CR221">221</xref>, 
 <xref ref-type="bibr" rid="CR222">222</xref>]. In an example targeting yeast infections, anti-
 <italic>Candida</italic> mAbs antibodies derived by the single human B cell method can enhance phagocytosis to protect against disseminated candidiasis [
 <xref ref-type="bibr" rid="CR223">223</xref>].
</p>
